+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Exosomes Market (2022-2027) by Product, Treatment, Workflow, Application, End User, and Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis.

  • PDF Icon


  • 180 Pages
  • September 2022
  • Region: Global
  • Infogence Global Research
  • ID: 5684500

Clinics in the United States Are Hailing Exosome Therapy for Anti-Aging as a New Miracle Cure

The Global Exosomes Market is estimated to be USD 810 Mn in 2022 and is expected to reach USD 1967.3 Mn by 2027, growing at a CAGR of 19.42%.

Market Dynamics

Market dynamics are forces that impact the prices and behaviors of the Global Exosomes Market stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.

As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

Market Segmentations

The Global Exosomes Market is segmented based on Product, Treatment, Workflow, Application, End User, and Geography.
  • By Product, the market is classified into Instruments and Kits & Reagents.
  • By Treatment, the market is classified into Diagnostics and Therapeutics.
  • By Workflow, the market is classified into Downstream Analysis and Isolation Methods.
  • By Application, the market is classified into Cardiovascular Diseases, Genetic Disorders, Infectious Diseases, Neurodegenerative Diseases, and Oncology.
  • By End User, the market is classified into Cancer Institutes, Diagnostic Centers, Hospitals, and Research Laboratories.
  • By Geography, the market is classified into Americas, Europe, Middle-East & Africa and Asia-Pacific.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Aegle Therapeutics Corporation, Anjarium Biosciences AG, Qiagen, System Biosciences, LLC, Takara Bio Company, Thermo Fisher Scientific Inc., etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

The report presents a detailed Ansoff matrix analysis for the Global Exosomes Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.

The analyst analyses the Global Exosomes Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.

Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Exosomes Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the analyst's competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market
Frequently Asked Questions about the Global Exosomes Market

What is the estimated value of the Global Exosomes Market?

The Global Exosomes Market was estimated to be valued at $810 Million in 2022.

What is the growth rate of the Global Exosomes Market?

The growth rate of the Global Exosomes Market is 19.4%, with an estimated value of $1967.3 Million by 2027.

What is the forecasted size of the Global Exosomes Market?

The Global Exosomes Market is estimated to be worth $1967.3 Million by 2027.

Who are the key companies in the Global Exosomes Market?

Key companies in the Global Exosomes Market include Aegle Therapeutics Corp., Anjarium Biosciences Ag, ArunA Bio, Inc., Bio, Techne Corp., Codiak BioSciences Inc., Danaher Corp., Diagenode Inc., Evox Therapeutics Ltd. and ExCoBio Inc..

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations, and Outlook
4 Market Dynamics
4.1 Drivers
4.1.1 Increased Use Exosomes as a Versatile Source of Biomarkers for Molecular Diagnostics
4.1.2 Increased Prevalence and Identification of Cancer, Heart Diseases, and Genetic Disorders
4.1.3 Advancements in Exosomes Isolation and Analytical Procedures
4.2 Restraints
4.2.1 Stringent Regulatory Requirement Limiting Commercialization
4.3 Opportunities
4.3.1 Use as Drug Delivery Systems for Small Molecules, DNA, RNA, and Other Biologic Payloads
4.3.2 Targeted Treatments and Opens Cell Therapy
4.3.3 Collaborated R&D Activity
4.4 Challenges
4.4.1 Technical Difficulties with Implementation and Usage of Exosomes
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
6 Global Exosomes Market, By Product
6.1 Introduction
6.2 Instruments
6.3 Kits & Reagents
7 Global Exosomes Market, By Treatment
7.1 Introduction
7.2 Diagnostics
7.3 Therapeutics
8 Global Exosomes Market, By Workflow
8.1 Introduction
8.2 Downstream Analysis
8.3 Isolation Methods
9 Global Exosomes Market, By Application
9.1 Introduction
9.2 Cardiovascular Diseases
9.3 Genetic Disorders
9.4 Infectious Diseases
9.5 Neurodegenerative Diseases
9.6 Oncology
10 Global Exosomes Market, By End User
10.1 Introduction
10.2 Cancer Institutes
10.3 Diagnostic Centers
10.4 Hospitals
10.5 Research Laboratories
11 Americas' Exosomes Market
11.1 Introduction
11.2 Argentina
11.3 Brazil
11.4 Canada
11.5 Chile
11.6 Colombia
11.7 Mexico
11.8 Peru
11.9 United States
11.10 Rest of Americas
12 Europe's Exosomes Market
12.1 Introduction
12.2 Austria
12.3 Belgium
12.4 Denmark
12.5 Finland
12.6 France
12.7 Germany
12.8 Italy
12.9 Netherlands
12.10 Norway
12.11 Poland
12.12 Russia
12.13 Spain
12.14 Sweden
12.15 Switzerland
12.16 United Kingdom
12.17 Rest of Europe
13 Middle East and Africa's Exosomes Market
13.1 Introduction
13.2 Egypt
13.3 Israel
13.4 Qatar
13.5 Saudi Arabia
13.6 South Africa
13.7 United Arab Emirates
13.8 Rest of MEA
14 APAC's Exosomes Market
14.1 Introduction
14.2 Australia
14.3 Bangladesh
14.4 China
14.5 India
14.6 Indonesia
14.7 Japan
14.8 Malaysia
14.9 Philippines
14.10 Singapore
14.11 South Korea
14.12 Sri Lanka
14.13 Thailand
14.14 Taiwan
14.15 Rest of Asia-Pacific
15 Competitive Landscape
15.1 Competitive Quadrant
15.2 Market Share Analysis
15.3 Strategic Initiatives
15.3.1 M&A and Investments
15.3.2 Partnerships and Collaborations
15.3.3 Product Developments and Improvements
16 Company Profiles
16.1 Aegle Therapeutics Corp.
16.2 Anjarium Biosciences Ag
16.3 ArunA Bio, Inc.
16.4 Bio-Techne Corp.
16.5 Codiak BioSciences Inc.
16.6 Danaher Corp.
16.7 Diagenode Inc.
16.8 Evox Therapeutics Ltd.
16.9 ExCoBio Inc.
16.10 Exosome Diagnostics
16.11 Fujifilm Holdings Corp.
16.12 HansaBioMed Life Sciences
16.13 Hitachi Ltd
16.14 Illumina, Inc.
16.15 JSR Corp.
16.16 Kimera Society Inc.
16.17 Lonza Group Ltd.
16.18 Miltenyi Biotec
16.19 Norgen Biotek Corp.
16.20 Qiagen
16.21 System Biosciences, LLC
16.22 Takara Bio Company
16.23 Thermo Fisher Scientific Inc.
17 Appendix
17.1 Questionnaire

Companies Mentioned

  • Aegle Therapeutics Corp.
  • Anjarium Biosciences Ag
  • ArunA Bio, Inc.
  • Bio-Techne Corp.
  • Codiak BioSciences Inc.
  • Danaher Corp.
  • Diagenode Inc.
  • Evox Therapeutics Ltd.
  • ExCoBio Inc.
  • Exosome Diagnostics
  • Fujifilm Holdings Corp.
  • HansaBioMed Life Sciences
  • Hitachi Ltd
  • Illumina, Inc.
  • JSR Corp.
  • Kimera Society Inc.
  • Lonza Group Ltd.
  • Miltenyi Biotec
  • Norgen Biotek Corp.
  • Qiagen
  • System Biosciences, LLC
  • Takara Bio Company
  • Thermo Fisher Scientific Inc.